ICD-10-CM Billable Code

N03.7

Chronic nephritic syndrome with diffuse crescentic glomerulonephritis

Clinical Classification Guidelines

Inclusion Terms

  • Chronic nephritic syndrome with extracapillary glomerulonephritis

Medical Intelligence & Overview

Chronic nephritic syndrome with diffuse crescentic glomerulonephritis, classified under ICD-10 code N03.7, is a kidney condition characterized by long-term inflammation of the glomeruli—the tiny filtering units within the kidneys. This condition involves significant damage to the glomeruli, including the development of crescent-shaped structures in the kidney tissue, which can impair kidney function over time. It is a serious condition that requires medical attention to manage its progression and associated symptoms.

Causes & Symptoms

Clinical Causes: Autoimmune diseases such as systemic lupus erythematosus Infections that affect the kidneys, like streptococcal infections Exposure to certain drugs or toxins Other glomerular diseases that lead to inflammation and crescent formation Idiopathic causes, where the exact reason is unknown

Key Symptoms: Blood in the urine (hematuria) Protein in the urine (proteinuria) High blood pressure (hypertension) Swelling in the legs, ankles, or around the eyes (edema) Reduced urine output or foamy urine Fatigue or general feeling of being unwell

Diagnostic & Treatment

Diagnosis Path: Diagnosing this condition involves a combination of medical history review, physical examination, and laboratory tests. Specific steps include: - Urinalysis to detect blood and protein in the urine - Blood tests to assess kidney function and detect inflammation - Kidney biopsy to examine tissue under a microscope, confirming crescent formations in the glomeruli and detailed assessment of tissue damage - Imaging studies such as ultrasound may be used to evaluate kidney size and structure The biopsy is vital for definitive diagnosis and to guide treatment planning.

Treatment Protocols: Managing chronic nephritic syndrome with crescentic glomerulonephritis involves several approaches aimed at controlling inflammation, preserving kidney function, and preventing complications. Treatment options include: - Immunosuppressive medications like corticosteroids and other agents to reduce immune system activity - Blood pressure control using antihypertensive drugs, especially those protecting kidney function, such as ACE inhibitors or ARBs - Plasmapheresis in severe cases to remove harmful antibodies - Dietary modifications to reduce salt intake and manage fluid balance - Regular monitoring of kidney function and blood pressure - Dialysis may become necessary if kidney function deteriorates significantly Treatment plans are personalized based on disease severity and individual response, under close medical supervision.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N03.7 a billable ICD-10 code?
Yes, N03.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N03.7?
Clinical documentation must specify the nature of Chronic nephritic syndrome with diffuse crescentic glomerulonephritis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

glomerulonephritis syndrome nephritic chronic crescentic diffuse